K.Vita: a feasibility study of a blend of medium chain triglycerides to manage drug-resistant epilepsy.
Schoeler NE, Orford M, Vivekananda U, Simpson Z, Van de Bor B, Smith H, Balestrini S, Rutherford T, Brennan E, McKenna J, Lambert B, Barker T, Jackson R, Williams RSB, Sisodiya SM, Eaton S, Heales SJR, Cross JH, Walker MC; K.Vita Study Group.
Schoeler NE, et al. Among authors: cross jh.
Brain Commun. 2021 Jul 23;3(4):fcab160. doi: 10.1093/braincomms/fcab160. eCollection 2021.
Brain Commun. 2021.
PMID: 34729477
Free PMC article.